We are live on ! Find out more
PIM

Platinum Investment Management Portfolio holdings

AUM $397M
1-Year Est. Return 63.96%
This Fund
S&P 500
This Quarter Est. Return
+15.75%
1 Year Est. Return
+63.96%
3 Year Est. Return
+135%
5 Year Est. Return
+149.46%
10 Year Est. Return
+636.06%
AUM
$5.05B
AUM Growth
+$579M
Cap. Flow
+$18.1M
Cap. Flow %
0.36%
Top 10 Hldgs %
56.49%
Holding
107
New
8
Increased
24
Reduced
25
Closed
9

Top Sells

Rank Stock Value
1
ATHM icon
Autohome
ATHM
+$103M
2
WB icon
Weibo
WB
+$78.5M
3
INTC icon
Intel
INTC
+$49.7M
4
SINA
Sina Corp
SINA
+$44.4M
5
BABA icon
Alibaba
BABA
+$35.4M

Sector Composition

Rank Sector Weight
1 Communication Services 21.45%
2 Technology 21.15%
3 Consumer Discretionary 18.79%
4 Industrials 14.36%
5 Energy 7.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
51
Johnson & Johnson
JNJ
$625B
$3.5M 0.07%
24,000
+7,339
+44% +$995K
CALY
52
Callaway Golf Company
CALY
$3.14B
$3.18M 0.06%
149,932
-125,028
-45% -$2.56M
DNTH icon
53
Dianthus Therapeutics
DNTH
$6.09B
$3.15M 0.06%
13,002
-3,401
-21% -$636K
NSTG
54
DELISTED
NanoString Technologies, Inc.
NSTG
$3.06M 0.06%
110,125
AGIO icon
55
Agios Pharmaceuticals
AGIO
$1.93B
$2.93M 0.06%
61,434
+10,351
+20% +$391K
LRCX icon
56
Lam Research
LRCX
$390B
$2.9M 0.06%
99,310
CHRS icon
57
Coherus Oncology
CHRS
$196M
$2.89M 0.06%
160,263
-7,974
-5% -$147K
AERI
58
DELISTED
Aerie Pharmaceuticals
AERI
$2.75M 0.05%
113,842
+11,193
+11% +$232K
XLRN
59
DELISTED
Acceleron Pharma
XLRN
$2.73M 0.05%
51,489
RVTY icon
60
Revvity
RVTY
$12.8B
$2.65M 0.05%
27,347
MRUS
61
DELISTED
Merus
MRUS
$2.4M 0.05%
170,112
+31,012
+22% +$499K
FULC icon
62
Fulcrum Therapeutics
FULC
$297M
$2.31M 0.05%
138,767
+63,767
+85% +$610K
ESPR
63
DELISTED
Esperion Therapeutics
ESPR
$2.29M 0.05%
+38,454
New +$1.73M
PRTA icon
64
Prothena Corp
PRTA
$450M
$2.23M 0.04%
140,943
-49,048
-26% -$526K
AAPL icon
65
Apple
AAPL
$4.57T
$2.07M 0.04%
28,192
-2,528
-8% -$163K
ALNY icon
66
Alnylam Pharmaceuticals
ALNY
$29.3B
$1.81M 0.04%
15,741
-6,914
-31% -$689K
PYPL icon
67
PayPal
PYPL
$50.5B
$1.78M 0.04%
16,437
DERM
68
DELISTED
Dermira, Inc.
DERM
$1.76M 0.03%
116,325
CSCO icon
69
Cisco
CSCO
$479B
$1.71M 0.03%
35,700
LIVN icon
70
LivaNova
LIVN
$4.2B
$1.71M 0.03%
22,698
SGMO
71
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.64M 0.03%
196,265
+27,680
+16% +$255K
ALEC icon
72
Alector
ALEC
$199M
$1.6M 0.03%
92,933
ORCL icon
73
Oracle
ORCL
$423B
$1.56M 0.03%
29,418
BPMC
74
DELISTED
Blueprint Medicines
BPMC
$1.53M 0.03%
19,094
+6,348
+50% +$475K
CCL icon
75
Carnival Corporation Ltd
CCL
$39.7B
$1.49M 0.03%
29,260

Similar funds

Platinum Investment Management's Q4 2019 Portfolio in Review

As of Q4 2019, Platinum Investment Management held 107 positions worth $5.05B, up 13% from $4.47B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Platinum Investment Management's Q4 2019 filing shows 8 new, 24 increased, 25 reduced and 9 closed positions. Its largest new stake was SLB Ltd: 1,078,572 shares worth $43.4M. The largest sale was Autohome, an estimated $103M.

By sector, the portfolio is most concentrated in Communication Services at 21% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Platinum Investment Management's largest Q4 2019 buy was SLB Ltd: 1,078,572 shares worth $43.4M.
  • Platinum Investment Management added most to Trip.com Group in Q4 2019, an estimated $76.3M increase.
  • Platinum Investment Management's biggest Q4 2019 reduction was Autohome, cutting an estimated $103M.
  • Platinum Investment Management fully exited Huazhu Hotels Group in Q4 2019, selling an estimated $9.49M.
  • Platinum Investment Management's ten largest holdings make up 56% of its $5.05B portfolio in Q4 2019.
  • Platinum Investment Management opened 8 new positions and closed 9 in Q4 2019.
  • Platinum Investment Management's portfolio value rose 13% quarter-over-quarter to $5.05B.

Based on Platinum Investment Management's 13F filing for Q4 2019, filed 13 Feb 2020.